4.6 Article

Serum BDNF levels, glycolipid metabolism in deficit schizophrenia: A case-control study

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocation

Andressa K. Matsumoto et al.

Summary: The study found that the PON1 Q allele and lower PON1 activities are associated with deficit schizophrenia (DS), indicating reduced quorum quenching abilities and defenses against lipoperoxidation. This suggests that decreased PON1 activity in DS may impair the innate immune system, predisposing individuals to neurotoxic effects of immune-inflammatory, oxidative, and nitrosative pathways and Gram-negative microbiota.

CNS SPECTRUMS (2021)

Review Neurosciences

Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases

Mingyue Wang et al.

Summary: BDNF is implicated in neuropsychiatric diseases and neurodegenerative diseases, with the conversion of proBDNF to mBDNF considered crucial for disease pathogenesis and potential therapeutic benefits. Proteases play a key role in this conversion process, both intracellularly and extracellularly.

BRAIN RESEARCH BULLETIN (2021)

Article Psychiatry

Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study

Shen Li et al.

Summary: This study revealed that patients with schizophrenia comorbid with type 2 diabetes mellitus have higher serum BDNF levels and better performance in delayed memory, suggesting a potential relationship between BDNF levels and cognitive function in this population.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

Article Clinical Neurology

Cerebral white matter changes in deficit and non-deficit subtypes of schizophrenia

An Sen Tan et al.

JOURNAL OF NEURAL TRANSMISSION (2020)

Review Environmental Sciences

Neuroanatomy of Patients with Deficit Schizophrenia: An Exploratory Quantitative Meta-Analysis of Structural Neuroimaging Studies

Tji Tjian Chee et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Review Psychology, Clinical

Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis

E. Bora et al.

PSYCHOLOGICAL MEDICINE (2017)

Article Psychiatry

Primary, Enduring Negative Symptoms: An Update on Research

Brian Kirkpatrick et al.

SCHIZOPHRENIA BULLETIN (2017)

Review Endocrinology & Metabolism

Diabetes and Schizophrenia

Jaana Suvisaari et al.

CURRENT DIABETES REPORTS (2016)

Article Psychiatry

Dose Equivalents for Antipsychotic Drugs: The DDD Method

Stefan Leucht et al.

SCHIZOPHRENIA BULLETIN (2016)

Review Clinical Neurology

Neurobiological background of negative symptoms

Silvana Galderisi et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)

Letter Clinical Neurology

Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorder

Kenji Hashimoto

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)

Review Neurosciences

Neurotrophin regulation of neural circuit development and function

Hyungju Park et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Article Psychiatry

Cognition and the five-factor model of the Positive and Negative Syndrome Scale in schizophrenia

Roberto Rodriguez-Jimenez et al.

SCHIZOPHRENIA RESEARCH (2013)

Article Clinical Neurology

Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology

Anilkumar Pillai et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)

Review Clinical Neurology

Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions

Kenji Hashimoto

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)

Review Psychiatry

Deficit schizophrenia: An overview of clinical, biological and treatment aspects

S. Galderisi et al.

EUROPEAN PSYCHIATRY (2009)

Article Psychiatry

Differences in glucose tolerance between deficit and nondeficit schizophrenia

Brian Kirkpatrick et al.

SCHIZOPHRENIA RESEARCH (2009)

Article Endocrinology & Metabolism

Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia

L. M. Spelman et al.

DIABETIC MEDICINE (2007)